C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/1999
10/21/1999	CA2325662A1 Regulable gene expression in gram-positive bacteria
10/21/1999	CA2325658A1 Gene coding for heliomicine and use thereof
10/21/1999	CA2325603A1 Pns cell lines and methods of use therefor
10/21/1999	CA2325602A1 Regulated target expression for screening
10/21/1999	CA2325601A1 Novel constructs for controlled expression of recombinant proteins in prokaryotic cells
10/21/1999	CA2325599A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999	CA2325598A1 Pyruvate carboxylase overexpression for enhanced production of oxaloacetate-derived biochemicals in microbial cells
10/21/1999	CA2325576A1 Recombinant proteins of treponema pallidum and their use for a syphilis vaccine
10/21/1999	CA2325575A1 Purification of cellular components that are substantially rna free
10/21/1999	CA2325565A1 Diagnosis of multiple sclerosis and other demyelinating diseases
10/21/1999	CA2325563A1 Artery- and vein-specific proteins and uses therefor
10/21/1999	CA2325560A1 Noncloning technique for expressing a gene of interest
10/21/1999	CA2325559A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
10/21/1999	CA2325390A1 Human stanniocalcin and uses thereof to inhibit adipogenesis
10/21/1999	CA2325344A1 Methods and means for obtaining modified phenotypes
10/21/1999	CA2325338A1 Conjugate vaccines for the prevention of dental caries
10/21/1999	CA2325332A1 Therapeutic agent for ngf
10/21/1999	CA2325330A1 Transferrin receptor genes of moraxella
10/21/1999	CA2325022A1 Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence
10/21/1999	CA2325013A1 Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation
10/21/1999	CA2325010A1 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
10/21/1999	CA2324992A1 U4, a member of the hematopoietin receptor superfamily
10/21/1999	CA2324988A1 Methods for treatment and prevention of infections
10/21/1999	CA2324981A1 Peptides
10/21/1999	CA2324870A1 Modified biological material
10/21/1999	CA2324480A1 Glaucoma therapeutics and diagnostics based on a novel human transcription factor
10/21/1999	CA2324376A1 Seed specific polycomb group gene and methods of use for same
10/21/1999	CA2323934A1 Nucleic acid sequences and proteins associated with aging
10/21/1999	CA2323789A1 Expression of alfin1 and methods for producing transgenic plants having increased root growth and root specific gene activation
10/21/1999	CA2323107A1 Novel molecules of the t129-related protein family and uses thereof
10/21/1999	CA2321965A1 Method of producing plants which are tolerant or resistant to herbicides
10/21/1999	CA2321592A1 High throughput dna sequencing vector
10/21/1999	CA2319089A1 5' ests and encoded human proteins
10/20/1999	EP0950718A1 Method for detecting dna with probe pna
10/20/1999	EP0950717A1 Diagnostic system and method for determining the presence of a genotoxic compound in a sample
10/20/1999	EP0950713A2 Recombinant adenoviral vector for gene transfer
10/20/1999	EP0950712A1 Yeast vectors and process for producing proteins with the use of the same
10/20/1999	EP0950711A2 Gonadotropin receptor
10/20/1999	EP0950710A2 Cells expressing a chimera receptor and their uses
10/20/1999	EP0950709A1 Antisense oligonucleotides for the inhibition of integrin alphaV-subunit expression
10/20/1999	EP0950707A1 Homologous recombination for universal donor cells and chimeric mammalian hosts
10/20/1999	EP0950666A1 Diagnostic and Therapy of diseases linked with HHV-8 infection with antibody against Kaposin or with Kaposin-derivated-peptides
10/20/1999	EP0950663A1 Method for stabilizing useful proteins and useful protein compositions
10/20/1999	EP0950112A1 Photolabile polymer array synthesis methods
10/20/1999	EP0950111A1 Methods using cre-lox for production of recombinant adeno-associated viruses
10/20/1999	EP0950110A1 Novel morphogen-responsive signal transducer and methods of use thereof
10/20/1999	EP0950109A1 Glyphosate resistant transgenic plants
10/20/1999	EP0950108A1 Streptococcus pneumoniae dna sequences
10/20/1999	EP0950107A1 Novel nucleic acid molecules from maize and their use for the production of modified starch
10/20/1999	EP0950106A1 Agl15 sequences in transgenic plants
10/20/1999	EP0950105A1 Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods
10/20/1999	EP0950104A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
10/20/1999	EP0950103A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/20/1999	EP0950102A1 Secreted proteins and polynucleotides encoding them
10/20/1999	EP0950101A1 Secreted proteins and polynucleotides encoding them
10/20/1999	EP0950100A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
10/20/1999	EP0950099A1 NOVEL flt-3 RECEPTOR AGONISTS
10/20/1999	EP0950098A1 Stable expression of triple helical proteins
10/20/1999	EP0950097A2 Compositions and methods for tumour therapy
10/20/1999	EP0950095A2 TISSUE TYPE PLASMINOGEN ACTIVATOR (t-PA) VARIANTS: COMPOSITIONS AND METHODS OF USE
10/20/1999	EP0950094A1 Soluble polypeptides with activity of the ns3 serine protease of hepatitis c virus, and process for their preparation and isolation
10/20/1999	EP0950093A2 Alpha-amylase fused to cellulose binding domain, for starch degradation
10/20/1999	EP0950092A2 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
10/20/1999	EP0950091A2 Aav split-packaging genes and cell lines comprising such genes for use in the production of recombinant aav vectors
10/20/1999	EP0950089A1 Methods for the production of bacteria containing eukaryotic genes
10/20/1999	EP0950064A1 Genes encoding transcriptional regulatory proteins from trichoderma reesei and uses thereof
10/20/1999	EP0950062A1 Protein markers for esophageal cancer
10/20/1999	EP0950060A1 Antisense inhibition of human adhesion molecules
10/20/1999	EP0949930A1 Thermostable phosphatases
10/20/1999	EP0832297A4 Methods and compositions for identifying osteogenic agents
10/20/1999	EP0797685B1 ANALYSIS OF GENE EXPRESSION BY DISPLAY OF 3'-END RESTRICTION FRAGMENTS OF cDNAs
10/20/1999	EP0769065A4 Methods for identifying inhibitors of integrin activation
10/20/1999	EP0705349B1 Parallel primer extension approach to nucleic acid sequence analysis
10/20/1999	CN1232545A Method of sorting birds in ovo
10/20/1999	CN1232510A Method of identifying antisense oligonuotide binding
10/20/1999	CN1232509A Catalytic nucleic acid and its medical use
10/20/1999	CN1232506A Regulatory sequence of cellulase cbh1 genes originating in trichoderma viride and system for mass-producing proteins or peptides therewith
10/20/1999	CN1232505A Nucleic acid sequences that encode cell growth regulatory protein and uses thereof
10/20/1999	CN1232504A 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of order designated mononegavirales
10/20/1999	CN1232503A Tumor necrosis factor related ligand
10/20/1999	CN1232502A Antibodies against avirulence/pathogenicity proteins of plant pathogens
10/20/1999	CN1232501A Modified TIE-2 -receptor ligands
10/20/1999	CN1232500A Neuritin, a neurogene
10/20/1999	CN1232499A Human growth gene and short stature gene region
10/20/1999	CN1232498A Guanine exchange factor of RHO GTPase and nucleic acid encoding it
10/20/1999	CN1232497A AGE-1 polypeptides and related molecules and methods
10/20/1999	CN1232469A RET ligand (RetL) for stimulating neural and renal growth
10/20/1999	CN1232468A Acquired resistance NPR genes and uses thereof
10/20/1999	CN1232467A Isolated nucleic acid molecule encoding cancer associated antigen, antigen itself, and uses thereof
10/20/1999	CN1232087A Polynucleotide molecules encoding neospora proteins
10/20/1999	CN1232086A Transcription factor controlling phenylpropanol biosynthesis pathway
10/20/1999	CN1232085A PCR determining primer for zaocys dhumnade, tortoise plastron and Oviductus ranae
10/19/1999	US5969215 Dna construct which is free of genes which specify resistance to antibiotics. the regeneration step may include callus formation on a hormone-free medium, particularly suitable for sugar beet.
10/19/1999	US5969214 Transgenic plants which modify the biosynthesis and degradation pathways of reserve polysaccharides in plants.
10/19/1999	US5969213 Methods and compositions for the production of stably transformed fertile monocot plants and cells thereof
10/19/1999	US5969211 Pantropic retroviral vectors for gene transfer in mollusks
10/19/1999	US5969210 Reporter gene produces a fluorescent protein, sorting insulin-producing pancreatic islet cells from non-insulin-producing pancreatic islet cells by fluorescence activated cell sorting (facs).
10/19/1999	US5969129 Purification of polynucleotides from polynucleotide/polysaccharide mixtures
10/19/1999	US5969128 Nucleic acid probes with terminal primary amine groups in a configuration for attachment of marker which is detectable by production of color or light; diagnosis of genetic disorders, oncogenes, viral/bacteria/parasitic diseases
10/19/1999	US5969127 Expression vector, regulated by sugar free environment, for controlling gene expression of rice encoded polypeptide in plant cell; increased stability of messenger rna

1 ... 3339 3340 3341 3342 3343 3344 3345 3346 3347 3348 3349 3350 3351 3352 3353 3354 3355 3356 3357 3358 3359 ... 4023